clofarabine has been researched along with Diffuse Large B-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baiocchi, R; Blum, KA; Byrd, JC; Devine, SM; Hamadani, M; Johnson, AJ; Lin, TS; Lozanski, G; Lucas, DM; Phillips, GS; Porcu, P; Smith, LL | 1 |
| Bhamidipati, PK; Cortes, J; Daver, N; Estrov, Z; Jabbour, E; Konoplev, S | 1 |
1 trial(s) available for clofarabine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Prolonged myelosuppression with clofarabine in the treatment of patients with relapsed or refractory, aggressive non-Hodgkin lymphoma.
Topics: Adenine Nucleotides; Aged; Arabinonucleosides; Clofarabine; Female; Hematopoiesis; Humans; Kinetics; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myeloablative Agonists; Neutropenia; Remission Induction; Salvage Therapy; Survival Analysis; Thrombocytopenia | 2009 |
1 other study(ies) available for clofarabine and Diffuse Large B-Cell Lymphoma
| Article | Year |
|---|---|
Epstein-Barr virus-induced CD30-positive diffuse large B-cell lymphoma in a patient with mixed-phenotypic leukemia treated with clofarabine.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Arabinonucleosides; Clofarabine; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Ki-1 Antigen; Leukemia; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged | 2013 |